Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax with or without Interferon-alpha in advanced renal cell cancer
NCT00445523Phase 2Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- May 2006
- Primary completion
- Jan 2008
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-5T4 in renal cell carcinoma (RCC), sponsored by Houston Methodist Research Institute. Started May 2006; status: completed.
02
Drugs
MVA-5T4
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00445523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445523.